ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Why China’s biotech boom may be unstoppable"
Episode Synopsis
Earlier this month, Curie.Bio CEO Zach Weinberg joined Post-Hoc Live to give his take on why he thinks investors should stay away from Chinese biotechs. Today, we’re joined by Cui Cui, the head of Asia healthcare research at Jefferies, to get her perspective on the China biotech boom, and why US pharma companies keep turning to China for their deals (and not to US startups).
More episodes of the podcast Post-Hoc Live
The plan to make more custom CRISPR therapies — w Kiran Musunuru & Rebecca Ahrens-Nicklas
03/11/2025
The fight over Metsera
03/11/2025
Breaking down the XBI — with Josh Schimmer
10/09/2025
Choosing the Endpoints 11
03/09/2025
In God we trust